{"product_id":"manual-of-hematopoietic-cell-transplantation-and-cellular-therapies-hardback-9780323798334","title":"Manual of Hematopoietic Cell Transplantation and Cellular Therapies (Hardback) 9780323798334","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eManual of Hematopoietic Cell Transplantation and Cellular Therapies\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eAuthoritative guidance on cell-based treatments from the world’s leading physicians and scientists\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eQaiser Bashir (Edited by), Elizabeth J. Shpall (Edited by), Richard E. Champlin (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323798334, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 23 March 2023\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e608 pages\u003cbr\u003e21.6 x 27.9 x 3.4 cm, 1.54 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eLed by authors from MD Anderson’s Stem Cell Transplantation and Cellular Therapy Department, the world’s largest and highly respected program at the forefront of rapidly advancing treatments in the field, Manual of Hematopoietic Cell Transplantation and Cellular Therapies is a comprehensive, focused reference covering the latest clinical developments and applications of stem cell transplant and cellular therapies for hematologic malignancies and solid tumors. This cutting-edge title, with a majority contribution from the MD Anderson Cancer Center and leading faculty from other academic institutions, covers breakthrough cell-based therapies for various diseases including lymphoma, multiple myeloma, leukemia, and select solid tumor and autoimmune diseases. This unique, definitive resource is essential for hematologists, fellows in hematology and immunotherapy, mid-level providers, pharmacists, and oncologists who refer patients for cell-based therapies.\u003cul\u003e \u003cli\u003e  \u003cp\u003eAddresses hematologic conditions including leukemia, lymphoma, and myeloma. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eOffers guidance on hematopoietic cell transplantation for solid tumors.   \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eCovers basic science principles, clinical aspects, pharmacology, radiation therapy, and disease-specific guidelines, including prevention and management of complications. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eDiscusses key topics such as hematopoietic cell collection, bone marrow harvesting, umbilical cord blood transplantation, CAR T-cell therapy, and patient\/donor selection and preparation of HCT. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eFeatures extensive summary boxes, bulleted content, and algorithms throughout for quick and easy reference. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eOffers team-based, clinically-focused coverage from world-renowned leaders in the field. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eAn eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. \u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003ePart One Introduction\u003c\/p\u003e \u003cp\u003eCh 1 Evolution of HCT, past, present, and future\u003c\/p\u003e \u003cp\u003eCh 2 Human leukocyte antigen\u003c\/p\u003e \u003cp\u003eCh 3 Introduction and basic science of chimeric antigen receptor therapies\u003c\/p\u003e \u003cp\u003eCh 4 Statistical methods in HCT and cellular therapies\u003c\/p\u003e \u003cb\u003e \u003c\/b\u003e\u003cp\u003ePart Two Methodology\u003c\/p\u003e \u003cp\u003eCh 5 Hematopoietic cell collection; bone marrow harvesting, apheresis, UCB\u003c\/p\u003e \u003cp\u003eCh 6 Leukapheresis and manufacturing of CAR cells\u003c\/p\u003e \u003cb\u003e \u003c\/b\u003e\u003cp\u003ePart Three General Clinical Aspects\u003c\/p\u003e \u003cp\u003eCh 7 Patient and donor selection and preparing for HCT\u003c\/p\u003e \u003cp\u003eCh 8 General management of patients undergoing HCT\u003c\/p\u003e \u003cp\u003eCh 9 Haploidentical HCT\u003c\/p\u003e \u003cp\u003eCh 10 Umbilical cord blood transplantation\u003c\/p\u003e \u003cp\u003eCh 11 Process and general management of patients undergoing CAR therapies\u003c\/p\u003e \u003cb\u003e \u003c\/b\u003e\u003cp\u003ePart Four Pharmacology and Radiation Therapy \u003c\/p\u003e \u003cp\u003eCh 12 Preparative regimens used in HCT and CAR therapies\u003c\/p\u003e \u003cp\u003eCh 13 Pharmacology of drugs used in HCT and CAR therapies\u003c\/p\u003e \u003cp\u003eCh 14 Role of radiation therapy in HCT and CAR therapies\u003c\/p\u003e \u003cb\u003e \u003c\/b\u003e\u003cp\u003ePart Five Disease-Specific Indications and Results \u003c\/p\u003e \u003cp\u003eCh 15 HCT in AML\u003c\/p\u003e \u003cp\u003eCh 16 CAR therapy in AML\u003c\/p\u003e \u003cp\u003eCh 17 HCT in ALL\u003c\/p\u003e \u003cp\u003eCh 18 CAR therapy in ALL\u003c\/p\u003e \u003cp\u003eCh 19 HCT in chronic leukemias; CML and CLL\u003c\/p\u003e \u003cp\u003eCh 20 HCT in MDS\u003c\/p\u003e \u003cp\u003eCh 21 HCT in myeloproliferative disorders\u003c\/p\u003e \u003cp\u003eCh 22 HCT in aplastic anemia\u003c\/p\u003e \u003cp\u003eCh 23 HCT in multiple myeloma\u003c\/p\u003e \u003cp\u003eCh 24 CAR therapy in multiple myeloma\u003c\/p\u003e \u003cp\u003eCh 25 HCT in light-chain amyloidosis\u003c\/p\u003e \u003cp\u003eCh 26 HCT in NHL\u003c\/p\u003e \u003cp\u003eCh 27 HCT in Hodgkin lymphoma\u003c\/p\u003e \u003cp\u003eCh 28 CAR therapy in lymphoma\u003c\/p\u003e \u003cp\u003eCh 29 HCT in rare malignancies\u003c\/p\u003e \u003cp\u003eCh 30 HCT for hematologic malignancies in HIV patients\u003c\/p\u003e \u003cp\u003eCh 31 HCT in solid tumors\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003ePart Six Prevention and Management of Complications\u003c\/p\u003e \u003cp\u003eCh 32 Infectious complications\u003c\/p\u003e \u003cp\u003eCh 33 Graft failure\u003c\/p\u003e \u003cp\u003eCh 34 Graft-versus-host disease\u003c\/p\u003e \u003cp\u003eCh 35 Miscellaneous complications of HCT\u003c\/p\u003e \u003cp\u003eCh 36 Cytokine release syndrome\u003c\/p\u003e \u003cp\u003eCh 37 Neurologic complications of CAR therapy (ICANS)\u003c\/p\u003e \u003cp\u003eCh 38 Miscellaneous complications of CAR therapy\u003c\/p\u003e \u003cp\u003eCh 39 Symptoms management and palliative care\u003c\/p\u003e \u003cp\u003eCh 40 Survivorship\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46650750140696,"sku":"9780323798334","price":158.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323798334.jpg?v=1694992067","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/manual-of-hematopoietic-cell-transplantation-and-cellular-therapies-hardback-9780323798334","provider":"Freshly Printed Books","version":"1.0","type":"link"}